Micron, Inc.
↗Minato-ku, Tokyo, Japan (with Kobe operations history)
Micron, Inc. is Japan's leading molecular imaging Contract Research Organization (CRO), founded in 2005 with expertise in medical imaging for clinical trials. As the first imaging CRO in Japan and Asia's largest imaging specialist team, Micron provides comprehensive clinical trial support with specialized expertise in PET (Positron Emission Tomography), MRI, CT, and SPECT imaging modalities. The company serves over 250 global clients and has contributed to the successful regulatory approval of over 40 pharmaceutical products. Micron is distinguished as the only CRO in Japan capable of establishing and auditing PET drug synthesis facilities compliant with Japan's unique GMP standards. In July 2025, Micron was acquired by Tigermed (acquiring 56.37% stake), integrating into Tigermed Japan's clinical operations network.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals/Biotechnology Services
Sub-Industry:Contract Research Organization (CRO) - Medical Imaging
SIZE & FINANCIALS
Employees:201-500
Founded:2005
Ownership:private
Status:operating
FUNDING
Stage:Post-Acquisition
Investors:Tigermed
PIPELINE
Stage:Clinical Development Support
Lead Drug Stage:Various (supports drugs across development stages)
Modalities:PET, MRI, CT, SPECT, Bone Scintigraphy, Endoscopy, Ultrasound, IVUS, OCT, Medical Photography, Videography, Fundus Photography, DeXA
Active Trials:50
Trial Phases:-
CORPORATE STRUCTURE
Parent Company:Tigermed (as of July 2025)
Acquired By:Tigermed (Hangzhou Tigermed Consulting Co., Ltd.) (2025-07-29)
Key Partnerships:AMRA Medical (2019 - exclusive partnership for clinical trials in Japan), Medical Metrics (collaboration on imaging services), Telemedicine Technologies (CRO Alliance collaboration), icometrix (collaboration for Asia expansion), Advanced Medical Center Kobe (founding support)
COMPETITION
Position:Leader
Competitors:Cardiovascular Research Foundation (CRF), Bioclinica, Medpace Holdings, Clintec International, Parexel International, PharmaNet Development Group, Charles River Laboratories
LEADERSHIP
Key Executives:
Makoto Sato - Founder & CEO
Scientific Founders:Physicians from Advanced Medical Center Kobe (founding support partners)
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Micron, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Micron, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.